Biomarin pharmaceutical market cap
WebApr 3, 2024 · BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. The company has a market cap of $18.07 billion, a price-to-earnings ratio of 131.41 and a beta of 0.39. WebBioMarin Pharmaceutical (BMRN) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund …
Biomarin pharmaceutical market cap
Did you know?
WebApr 13, 2024 · The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. The business's fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. WebMar 22, 2024 · BioMarin Pharmaceutical Inc. (BMRN) NASDAQ: BMRN · IEX Real-Time Price · USD. Add to Watchlist 90.08-2.00 (-2.17%) ... Profile; Chart; BMRN Market Cap. …
WebAccording to BioMarin Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $2.09 B . In 2024 the company made a revenue of $1.84 B a decrease over the years 2024 revenue that were of $1.86 B .The revenue is the total amount of income that a company generates by the sale of goods or services. WebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California.It has offices and facilities in the United States, South America, …
WebBioMarin Pharmaceutical Symbol: BMRNRank: #820Price: $111.81(-0.9128%) Market Cap: $20.7B($-189.6M)Industry: BiotechnologySector: HealthcareCountry: United StatesInsiders: 0.552%Institutions: 101.394% BioMarin Pharmaceutical Inc. Technicals 52 Week High: $114.8 52 Week Low: $70.73 50 Day MA: $99.43 200 Day MA: $88.59 WebApr 13, 2024 · BioMarin Pharmaceutical Stock Performance NASDAQ:BMRN opened at $97.96 on Thursday. The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. The...
WebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of …
Web24 rows · As of March 2024 BioMarin Pharmaceutical has a market cap of $16.71 Billion. This makes BioMarin Pharmaceutical the world's 978th most valuable company by market cap according to our data. The … cheap womens pumpsWebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of $70.73 and a twelve month high... cheap womens rab jacketsWebApr 10, 2024 · BMRN Complete BioMarin Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. … cheap womens north face winter coatsWebOur data points out that BioMarin Pharmaceutical Inc. (BMRN) is ranked #820 out of 13000 companies on February - 2024. BMRN's Market Capitalization is $20.7 billion … cheap womens pyjamasWebApr 11, 2024 · The firm has a market capitalization of $18.29 billion, a P/E ratio of 132.50 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a fifty-two week low of $70.73 and a fifty-two week high... cycling hattiesburgWeb26 rows · Mar 22, 2024 · Biomarin Pharmaceutical Market Cap: 17.44B for March 29, 2024. Market Cap Chart. Historical Market Cap Data. View and export this data back to … cycling hats capsWebApr 10, 2024 · Biomarin Pharmaceutical Inc.'s market capitalization is $18.49 B by 186.53 M shares outstanding. Is Biomarin Pharmaceutical stock a Buy, Sell or Hold? … cycling hat under helmet customize